Next Article in Journal
Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies
Next Article in Special Issue
Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives
Previous Article in Journal
Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study
Previous Article in Special Issue
Treating Epilepsy with Natural Products: Nonsense or Possibility?
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(9), 1191; https://doi.org/10.3390/ph16091191
Action Date Notes Link
article xml file uploaded 22 August 2023 09:18 CEST Original file -
article xml uploaded. 22 August 2023 09:18 CEST Update -
article pdf uploaded. 22 August 2023 09:18 CEST Version of Record https://www.mdpi.com/1424-8247/16/9/1191/pdf-vor
article html file updated 22 August 2023 09:20 CEST Original file -
article xml file uploaded 27 September 2023 08:11 CEST Update -
article xml uploaded. 27 September 2023 08:11 CEST Update https://www.mdpi.com/1424-8247/16/9/1191/xml
article pdf uploaded. 27 September 2023 08:11 CEST Updated version of record https://www.mdpi.com/1424-8247/16/9/1191/pdf
article html file updated 27 September 2023 08:12 CEST Update https://www.mdpi.com/1424-8247/16/9/1191/html
Back to TopTop